FDA Chief Pushed Out in Latest Sign of Public Health Chaos Under RFK Jr. – Democracy Now!
FDA Chief Pushed Out in Latest Sign of Public Health Chaos Under RFK Jr. Democracy Now!
FDA Proposes to Exclude GLP-1s From 503B Bulk List – Drug Topics
FDA Proposes to Exclude GLP-1s From 503B Bulk List Drug Topics
FDA Proposes to Exclude GLP-1s From 503B Bulk List – Drug Topics Read Post »
Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial – Nature
Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial Nature
The truth about peptides that social media won’t tell you – Scientific American
The truth about peptides that social media won’t tell you Scientific American
The truth about peptides that social media won’t tell you – Scientific American Read Post »
Entera Announces First Quarter 2026 Financial Results and Updates Across its Oral Peptide Programs – GlobeNewswire
Entera Announces First Quarter 2026 Financial Results and Updates Across its Oral Peptide Programs GlobeNewswire
The role of electroacupuncture in altering lipoic acid metabolism to reduce joint inflammation in rheumatoid arthritis rats.
This rat study demonstrates that low-intensity electroacupuncture reduces rheumatoid arthritis inflammation by modulating lipoic acid metabolism and copper homeostasis, with effects comparable to methotrexate. The research identifies DLAT and LIAS proteins as key metabolic targets and shows serum copper levels correlate with anti-inflammatory outcomes. The findings suggest copper-dependent peptide compounds like GHK-Cu may offer a novel therapeutic angle for RA management through metabolic pathway modulation rather than immune suppression alone.
Protective effects of BPC 157 in rats with experimentally induced lower extremity ischemia-reperfusion injury.
A peer-reviewed rat study demonstrated that BPC-157 significantly protects against ischemia-reperfusion injury in lower limb skeletal muscle by reducing oxidative stress markers (MDA, TOS), restoring antioxidant capacity (SOD, TAS), suppressing apoptotic pathways (p53, Bax, Caspase-3), and reducing inflammatory cytokines (IL-6). The compound also partially restored angiogenic signaling (VEGF) and improved histological muscle architecture with reduced fibrosis. This positions BPC-157 as a potential therapeutic option for peripheral arterial disease complications, a significant clinical indication with clear practitioner relevance.
Intracellular NAD+ Depletion Increases Prostanoid Production via p38/COX2 Signalling in FK866-Induced Senescent Human Umbilical Vein Endothelial Cells.
This study demonstrates that NAD+ depletion in vascular endothelial cells triggers a senescence-like state that increases production of pro-inflammatory prostanoids (PGF1α and TXB2) via p38 MAPK and COX2 activation. Using FK866 to deplete NAD+, researchers showed this pathway drives vascular dysfunction associated with aging and cardiovascular disease. Crucially, NMN supplementation reversed NAD+ depletion, suppressed the senescence phenotype, and attenuated prostanoid overproduction, suggesting NAD+ restoration as a therapeutic target for age-related vascular pathology.
Nicotinamide Ameliorates Deoxynivalenol-Induced Injury in Renal Cells via Inhibiting PARP1 Hyperactivation and Restoring NAD+ Homeostasis.
This in vitro study demonstrates that the mycotoxin deoxynivalenol (DON) causes severe renal cell damage primarily through PARP1 hyperactivation and consequent NAD+ depletion, rather than through NAMPT inhibition as previously thought. Nicotinamide (NAM) successfully rescued cells by suppressing PARP1 activity and restoring NAD+ pools, while NMN supplementation alone did not protect against DON toxicity. The findings suggest that NAD+ restoration strategies targeting PARP1 inhibition may offer therapeutic value for mycotoxin exposure, relevant to practitioners considering NAD+-supporting interventions for clients with food safety concerns or oxidative stress conditions.
Protective Effect of Liriope platyphylla Root Extract on Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice.
This study demonstrates that Liriope platyphylla root extract alleviates DSS-induced ulcerative colitis in mice through suppression of inflammatory cytokines, inhibition of NF-κB and MAPK signaling pathways, and modulation of gut microbiota composition. The findings position natural plant compounds as potential therapeutic alternatives to conventional UC treatments, operating through well-characterized anti-inflammatory and microbiota-balancing mechanisms. This is relevant to Annular’s peptide portfolio because BPC-157 shares similar mechanistic targets (NF-κB inhibition, gut barrier restoration, microbiota modulation) in inflammatory bowel disease models, supporting a complementary or comparative positioning strategy.
Targeting the Gut-Brain Axis: Protective Effects of NMN in Alleviating D-Galactose-Induced Cognitive Deficits.
This peer-reviewed study demonstrates that NMN, an NAD+ precursor, protects against age-related cognitive decline in mice by reducing oxidative stress, suppressing neuroinflammation, and modulating gut microbiota composition toward butyrate-producing bacteria. The mechanism involves activation of the Nrf2/HO-1 antioxidant pathway and increased antioxidant enzyme activity in the hippocampus. These findings support NMN as a therapeutic strategy for age-related neurodegeneration via gut-brain axis modulation at doses of 300-500 mg/kg.
The GHK-Cu delays aging in Caenorhabditis elegans via coordinated regulation of mitochondrial function and activation of DAF-16/SKN-1 pathways.
This groundbreaking study in C. elegans worms demonstrates that GHK-Cu significantly extends lifespan and improves multiple age-related health markers including stress resistance, mobility, and cellular function. The research identified specific molecular mechanisms: GHK-Cu preserves mitochondrial function by increasing membrane potential and promoting cellular energy production, while activating key longevity pathways (DAF-16 and SKN-1) that regulate antioxidant defenses. This is the first study to provide mechanistic evidence for GHK-Cu’s anti-aging effects through coordinated mitochondrial and cellular pathway regulation. The findings establish GHK-Cu as a validated geroprotective compound with defined molecular targets for anti-aging interventions.